Allspring Global Investments Holdings LLC Sells 72,498 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Allspring Global Investments Holdings LLC decreased its stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 54.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 59,543 shares of the medical instruments supplier's stock after selling 72,498 shares during the period. Allspring Global Investments Holdings LLC owned 0.24% of ICU Medical worth $9,407,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. FMR LLC increased its stake in shares of ICU Medical by 2,676.6% in the third quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier's stock worth $18,968,000 after purchasing an additional 100,345 shares in the last quarter. State Street Corp increased its stake in shares of ICU Medical by 9.3% in the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock worth $165,384,000 after purchasing an additional 77,506 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of ICU Medical by 9.6% in the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock worth $99,687,000 after purchasing an additional 48,106 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of ICU Medical by 10.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier's stock worth $54,868,000 after purchasing an additional 27,927 shares in the last quarter. Finally, Principal Financial Group Inc. increased its stake in shares of ICU Medical by 24.6% in the third quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier's stock worth $23,130,000 after purchasing an additional 25,031 shares in the last quarter. Institutional investors own 96.10% of the company's stock.

Insider Activity at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $162.91, for a total transaction of $1,954,920.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at $17,039,245.63. The trade was a 10.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Christian B. Voigtlander sold 1,430 shares of ICU Medical stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total transaction of $225,940.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 17,737 shares of company stock valued at $2,879,752. Corporate insiders own 6.70% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on ICUI shares. KeyCorp lifted their target price on shares of ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 13th. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research note on Wednesday, November 13th. Jefferies Financial Group raised shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price objective for the company in a research note on Wednesday, December 11th. Finally, StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research note on Wednesday, November 20th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $199.67.

ICU Medical Price Performance

NASDAQ:ICUI traded down $5.73 during mid-day trading on Friday, hitting $157.42. 159,367 shares of the stock traded hands, compared to its average volume of 190,553. The business's 50-day moving average price is $160.82 and its 200 day moving average price is $165.36. The company has a market cap of $3.85 billion, a PE ratio of -34.45 and a beta of 0.63. ICU Medical, Inc. has a 12-month low of $93.36 and a 12-month high of $196.26. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.